MBHB Partner Kevin Noonan shares insights into the FTC’s ongoing junk patent crackdown
June 25, 2024
In Fierce Pharma, MBHB Partner Kevin Noonan discusses the latest in the FTC’s campaign against junk patents and shares thoughts on possible next steps from the FTC and pharma companies. View the article.
